The Effect of Menstrual Cycle On IL-6, TNF-α And Periodontal Status
NCT ID: NCT03281109
Last Updated: 2018-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
25 participants
OBSERVATIONAL
2017-07-26
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Material and methods: Twenty-five patients were included in this study clinical periodontal parameters and levels of IL-6 and TNF α in gingival crevicular fluid were evaluated at three periods of menstrual cycle (menstruation day (MD)-ovulation day(OD)-premenstruation day (PmD)). Levels of IL-6 and TNF α in gingival crevicular fluid were determined by ELISA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hepcidin Levels in Periodontal Health and Disease
NCT03789565
GCF Levels of IL-1Beta, MIP-1 Alfa and G-CSF in Gingivitis and Stage I-II-III-IV Periodontitis Patients
NCT04629313
GCF Levels of IL-1β and IL-6 in Gingivitis and Stage III-Grade C Periodontitis
NCT04689438
Analysis of Gingival Crevicular Fluid
NCT05325905
Assessment of Salivary GM-CSF, MIP, and IL-1β Levels in Subjects With Varying Periodontal Conditions
NCT06961409
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sixty women were initially included in this longitudinal, prospective study in Yuzuncu Yil University, Faculty of Dentistry, Department of Periodontology.
The procedure was accepted and informed consent was signed by all participants. The material and method used in the trial were accepted by the Yuzuncu Yil University Ethics Committee and were found to conform to the guidelines issued in the Declaration of Helsinki. To standardize the effect of plaque accumulation on the tested parameters, subjects were given oral hygiene instructions before the study.
Clinical Procedures, and Measurements
All subjects were scheduled for periodontal measurements and GCF sampling on the specific days determined as follows: 1) menstruation day (MD); on days 2-3 of menstruation 2) ovulation day (OD); detected by saliva fertility microscope 12-14 days of menstrual cycle and 3) premenstruation day (PmD); 22-24 days of menstruation cycle.
The subjects evaluated the study criteria in terms of the duration of a regular menstrual cycle (28 ± 3 d) and were followed up for three menstrual cycles. Five participants were excluded from the study if their menstrual cycles were longer or shorter than 28 ± 3 d for the last 12 months.
Donna ® Saliva Fertility Tester was used to detect the ovulation day. Patients also made their own fever measurement and confirmed the ovulation day. A small amount of saliva was placed onto microscope and after 5 minutes results were evaluated according to manufacturer's instructions. The outside of microscope lens cleaned with alcohol and a cotton swab after each use.
Periodontal measurements were performed for all patients at each of the three time points from index teeth. Periodontal measurements were: 1) plaque index (PI) (according to Silness and Löe index) 9: measured at six sites around each tooth; the highest score per tooth was recorded; 2) gingival index (GI) (according to Löe and Silness index) 10: measured at six sites around each tooth; the highest score per tooth was recorded; 3) probing depth (PD): measured at six sites around each tooth.
The GCF samples were obtained for 30 seconds from the mesiobuccal gingival sulcus of teeth using periodontal paper strips . The samples were taken 3 hours after the patients brush their teeth in the morning.
To avoid irritation of the periodontal pocket epithelium, the clinical measurements were obtained after the GCF samples collecting. The area was isolated with cotton rolls. All paper strips were stored in phosphate buffered solution. Paper points contaminated with blood and saliva were not used for study. GCF samples were stored at -80 °C for laboratory analyses. GCF samples were analyzed for IL-6 and TNF-α using commercially available sandwich enzyme-linked immunosorbent assay according to the manufacturer's instructions. Results were reported as concentrations of IL-6 and TNF-α in GCF.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diagnosis
diagnosis with ELISA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. normal and steady menstrual cycle (25 to 31 days long);
3. available for clinical examination;
4. non-smoking;
5. antibiotic therapy or use of nonsteroidal anti-inflammatory drugs within the past 6 months;
6. healthy systemic status;
7. normal body mass index;
8. healthy periodontium.
Exclusion Criteria
2. use of oral contraceptives;
3. metabolic or systemic condition that might affect the periodontium;
4. antibiotic therapy or use of nonsteroidal anti-inflammatory drugs within the past 6 months;
5. periodontitis;
6. smoking and
7. with the diagnosis of polycystic over or hyperandrogenism according to Rotterdam diagnostic criteria
20 Years
29 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yuzuncu Yıl University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hacer Sahin Aydinyurt
assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hacer sahin aydinyurt
Role: STUDY_DIRECTOR
yuzuncu yil universtiy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yuzuncu Yıl University
Van, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YuzuncuYıl4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.